Regenerative MedicineNanomedicine Awakens Dormant Repair Cells to Drive Tissue Regeneration
Researchers from India's Agharkar Research Institute review how emerging nanomedicine tools — including lipid nanoparticles, ROS-sensitive polymers, hydrogels, and extracellular vesicles — can precisely deliver therapeutic agents to damaged or fibrotic tissues. A key insight is that aged and dysfunctional cells retain latent regenerative capacity that can be reawakened through metabolic reprogramming: restoring mitochondrial function and redox balance effectively rejuvenates these cells. Immune engineering plays an equally important role, with nanoparticle-driven shifts in macrophage behavior from the pro-inflammatory M1 state to the tissue-repairing M2 state helping resolve chronic inflammation. Together, these approaches form a multifunctional therapeutic framework aimed at dismantling molecular, epigenetic, and microenvironmental barriers that normally block tissue repair — a compelling frontier for anyone interested in regenerative medicine and aging.
